Tivic Health Systems, Inc. 8-K

What Happened

• Tivic Health Systems, Inc. filed a Certificate of Amendment with the Delaware Secretary of State on April 22, 2026, to change its corporate name to Valion Bio, Inc., effective April 28, 2026. The company issued a press release announcing the name change on April 23, 2026.
• The change does not affect shareholder rights and, under Delaware law, did not require a shareholder vote. The company’s common stock (par value $0.0001 per share) is expected to stop trading under the ticker “TIVC” and begin trading under “VBIO” on The Nasdaq Capital Market, effective April 28, 2026.

Key Details

• Certificate of Amendment filed: April 22, 2026 (effective April 28, 2026).
• Press release announcing name change: issued April 23, 2026 (filed as Exhibit 99.1).
• Ticker change expected: from TIVC → VBIO on Nasdaq, effective April 28, 2026.
• Shareholder rights and capital structure: no changes noted in the filing.

Why It Matters

• For investors, this is a corporate rebranding and ticker change, not a change to shareholder rights or company capitalization. Update watchlists and brokerage records to the new ticker (VBIO) on or after April 28, 2026 to track trading correctly. Check the company’s subsequent filings and communications for any additional context about strategic reasons behind the name change.